Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Beard

Showing results (491-500 of 576) with videos related to

Pageof 58
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate CancerYu-Wei Chen, Brandon A Mahal, Vinayak Muralidhar, et al.
Neuropathology and Applied Neurobiology|April 6, 2023
Tuberous sclerosis complex-1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's diseaseBryan A Adriaanse, Sinead Brady, Minghui Wang, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancerP L Nguyen, N E Martin, V Choeurng, et al.
Translational Stroke Research|September 27, 2024
Rapamycin Treatment Reduces Brain Pericyte Constriction in Ischemic StrokeDaniel J Beard, Lachlan S Brown, Gary P Morris, et al.
Brachytherapy|April 19, 2015
Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancerVinayak Muralidhar, Brandon A Mahal, David R Ziehr, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen LevelVinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Molecular Urology|November 4, 2000
Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Health Technology Assessment (Winchester, England)|May 6, 2020
Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCTDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Lancet (London, England)|July 22, 2019
The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trialDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Pageof 58

Showing results (491-500 of 576) with videos related to

Sort By:
Pageof 58
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate CancerYu-Wei Chen, Brandon A Mahal, Vinayak Muralidhar, et al.
Neuropathology and Applied Neurobiology|April 6, 2023
Tuberous sclerosis complex-1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's diseaseBryan A Adriaanse, Sinead Brady, Minghui Wang, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancerP L Nguyen, N E Martin, V Choeurng, et al.
Translational Stroke Research|September 27, 2024
Rapamycin Treatment Reduces Brain Pericyte Constriction in Ischemic StrokeDaniel J Beard, Lachlan S Brown, Gary P Morris, et al.
Brachytherapy|April 19, 2015
Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancerVinayak Muralidhar, Brandon A Mahal, David R Ziehr, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen LevelVinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Molecular Urology|November 4, 2000
Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Health Technology Assessment (Winchester, England)|May 6, 2020
Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCTDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Lancet (London, England)|July 22, 2019
The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trialDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Pageof 58